2026-09-02T14:09:54-05:00 2025-12-31 331374517 PKF O'CONNOR DAVIES ADVISORY LLC 150 PRESIDENTIAL WAY SUITE 510 WOBURN MA 01801 990 2025-01-01 463020006 GLOUCESTER MARINE GENOMICS INSTITUTE INCORPORATED GLOU 9788794575 417 MAIN STREET GLOUCESTER MA 01930 BONNIE FENDROCK EXECUTIVE DIRECTOR 9788794575 2026-09-02 1 EVA MRUK P00543254 7819375300 2026-08-31 2025 BONNIE FENDROCK 417 MAIN STREET GLOUCESTER MA 01930 4255401 0 X WWW.GMGI.ORG X 2013 MA GLOUCESTER MARINE GENOMICS INSTITUTE (GMGI) WAS ESTABLISHED IN 2013. GMGI'S MISSION IS TO ADDRESS CRITICAL CHALLENGES FACING OUR OCEANS, HUMAN HEALTH AND THE ENVIRONMENT THROUGH INNOVATIVE SCIENTIFIC RESEARCH AND EDUCATION. BY BRINGING WORLD-CLASS SCIENCE AND TRANSFORMATIVE WORKFORCE DEVELOPMENT TO GLOUCESTER'S HISTORIC WATERFRONT, GMGI IS CATALYZING THE REGIONAL ECONOMY. 10 10 49 89 0 0 9715449 4075582 109987 138513 22971 35063 8451 6243 9856858 4255401 177601 278564 0 0 3696348 3734328 0 0 316644 1965525 1933718 5839474 5946610 4017384 -1691209 13172949 13631201 1867136 1458279 11305813 12172922 X GLOUCESTER MARINE GENOMICS INSTITUTE ADDRESES CRITICAL CHALLENGES FACING OUR OCEANS, HUMAN HEALTH AND THE ENVIRONMENT THROUGH INNOVATIVE SCIENTIFIC RESEARCH AND EDUCATION. BY BRINGING WORLD-CLASS SCIENCE AND TRANSFORMATIVE WORKFORCE DEVELOPMENT TO GLOUCESTER'S HISTORIC WATERFRONT, GMGI IS CATALYZING THE REGIONAL ECONOMY. 0 0 2617901 0 123938 RESEARCH - GMGI'S RESEARCH IS AT THE FOREFRONT OF GENOMIC INNOVATION TO ADVANCE OUR UNDERSTANDING OF THE OCEANS, INFORM EFFECTIVE CONSERVATION MANAGEMENT, PROMOTE SUSTAINABLE FISHERIES, AND UNCOVER NEW DISCOVERIES THAT IMPACT HUMAN HEALTH. THE RESEARCH PROGRAM HAS TWO MAIN DIVISIONS: 1) HEALTHY OCEANS AND FISHERIES AND 2) MARINE BIOMEDICAL DISCOVERY. 1710856 278564 14575 GLOUCESTER BIOTECHNOLOGY ACADEMY - GLOUCESTER BIOTECHNOLOGY ACADEMY IS THE VIBRANT EDUCATIONAL ARM OF GMGI. THE ACADEMY PROVIDES TUITION-FREE LABORATORY TRAINING THAT PREPARES YOUNG ADULTS FOR CAREERS IN BIOTECHNOLOGY, WITHOUT NEEDING A FOUR-YEAR DEGREE. STUDENTS TRAIN IN PROFESSIONAL TEACHING LABORATORIES, LEARNING TECHNIQUES USED BY WORKING SCIENTISTS, FROM DNA ANALYSIS AND CELL CULTURE TO BIOMANUFACTURING. THEY ALSO COMPLETE PAID CO-OPS WITH BIOTECHNOLOGY COMPANIES ACROSS THE NORTH SHORE, BOSTON, AND CAMBRIDGE. IN LESS THAN A YEAR, GRADUATES GAIN THE SKILLS, CONFIDENCE, AND INDUSTRY CONNECTIONS NEEDED TO LAUNCH CAREERS IN THE LIFE SCIENCES. OUR SUMMER STEM PROGRAMS ARE ONE-WEEK COURSES DESIGNED TO PROVIDE STUDENTS WITH THE OPPORTUNITY TO EXPERIENCE HANDS-ON SCIENCE IN A BIOTECHNOLOGY LABORATORY. HELD IN STATE-OF-THE-ART TEACHING LABS AT GLOUCESTER BIOTECHNOLOGY ACADEMY, THE CURRICULA IMMERSE STUDENTS IN AUTHENTIC LABORATORY INVESTIGATIONS. STUDENTS USE CUTTING-EDGE BIOTECHNOLOGY EQUIPMENT, THE SCIENTIFIC METHOD, AND CRITICAL THINKING TO ANALYZE SAMPLES AND MAKE DATA-DRIVEN CONCLUSIONS. 4328757 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 53 0 49 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 10 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA X X ELIZABETH LANDERGREN 9788794575 417 MAIN STREET GLOUCESTER MA 01930 MARC VIDAL PRESIDENT 1.00 X X 0 0 0 MICHELE MAY BOARD CHAIR & TREASURER 4.00 X X 0 0 0 TOM SIMONS DIRECTOR/CLERK 2.00 X X 0 0 0 JOSE-CARLOS GUTIERREZ-RAMOS DIRECTOR 1.00 X 0 0 0 BILL KANE DIRECTOR 2.00 X 0 0 0 JOHN O'CONNOR DIRECTOR 2.00 X 0 0 0 GEORGE PUTNAM DIRECTOR 2.00 X 0 0 0 LAURA SEN DIRECTOR 2.00 X 0 0 0 DAVID WALT DIRECTOR 1.00 X 0 0 0 JIM WESTRA DIRECTOR 1.00 X 0 0 0 CHRISTINE BOLZAN EXECUTIVE DIRECTOR, THRU 03/2025 40.00 X 68011 0 283 BONNIE FENDROCK EXECUTIVE DIRECTOR, AS OF 03/2025 40.00 X 185086 0 2101 KERSTEN LANES DIRECTOR OF FINANCE AND ADMIN. 40.00 X 152610 0 1146 ANDREA BODNAR SCIENCE DIRECTOR 40.00 X 219761 0 23131 JOHN DOYLE EDUCATION DIRECTOR 40.00 X 134375 0 39578 LAURA RICHANE DIRECTOR OF PARTNERSHIP & ENROLLMENT 40.00 X 126855 0 37122 LOGAN WALSH DEVELOPMENT DIRECTOR, THRU 8/2025 40.00 X 114217 0 14896 ANN PETERSEN RESEARCH PROGRAM DIRECTOR 40.00 X 117429 0 8296 COLETTE O'NEIL DIRECTOR OF COMMUNICATIONS 40.00 X 132718 0 34403 1251062 0 160956 9 0 1 0 0 1384210 2691372 37251 4075582 RESEARCH SUPPORT 541700 123938 123938 TUITION REVENUE 611430 14575 14575 138513 35063 35063 OTHER REVENUE 900099 5969 5969 SWAG REVENUE 900099 274 274 6243 4255401 138513 0 41306 98788 98788 179776 179776 652129 242892 409237 2523528 1826445 467786 229297 299560 185850 90329 23381 259111 165989 74551 18571 69581 69581 82029 40386 38760 2883 8404 6266 1199 939 121788 83542 26721 11525 118845 79124 30962 8759 334418 318895 8694 6829 105019 98648 3572 2799 35549 26503 5072 3974 6067 6067 534276 526337 5293 2646 39809 1089 38720 LAB CONSUMABLES 310361 310049 283 29 REPAIRS AND MAINTENANCE 72346 54737 14482 3127 SERVICE POLICIES 44537 44446 82 9 MISC OPERATING EXPENSES 23677 16252 7425 27012 22743 2393 1876 5946610 4328757 1301209 316644 275299 228549 2235648 2467277 6113008 6761686 109214 162074 6283732 3395115 3077905 2888617 1361875 1122998 13172949 13631201 205339 215681 164267 4500 91643 71145 1405887 1166953 1867136 1458279 X 5000052 5243026 6305761 6929896 11305813 12172922 13172949 13631201 -1691209 2558318 0 X X 0 1 X 1 0 X 3613857 4770781 5507601 9715449 4075582 27683270 3613857 4770781 5507601 9715449 4075582 27683270 907922 26775348 2405 15666 20017 22971 35063 96122 16342 4146 1067 8451 6243 36249 27815641 592688 0.96260 0.97500 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER REVENUE - 2021 AMOUNT: $ 16,342. 2022 AMOUNT: $ 3,415. 2023 AMOUNT: $ 630. 2024 AMOUNT: $ 7,896. 2025 AMOUNT: $ 5,969. SWAG REVENUE - 2022 AMOUNT: $ 731. 2023 AMOUNT: $ 437. 2024 AMOUNT: $ 555. 2025 AMOUNT: $ 274. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3535899 1338387 2197512 2747833 2056728 691105 2888617 OPERATING LEASE RIGHT-OF-USE ASSET 1122998 1122998 OPERATING LEASE LIABILITY 1166953 1166953 X 7171020 2915619 2915619 4255401 0 4255401 6303911 357301 357301 5946610 0 5946610 PART X, LINE 2: GAAP PRESCRIBES THE THRESHOLD A TAX POSITION IS REQUIRED TO MEET BEFORE BEING RECOGNIZED IN THE FINANCIAL STATEMENTS. THE TAX-EXEMPT STATUS OF AN ENTITY IS CONSIDERED A TAX POSITION. AN ADDITIONAL LIABILITY FOR UNCERTAIN TAX POSITIONS ("UTPS") IS RECOGNIZED AND RECORDED AS A COMPONENT OF CURRENT INCOME TAX EXPENSE FOR DIFFERENCES BETWEEN FINANCIAL AND INCOME TAX REPORTING POSITIONS WHICH DO NOT MEET THIS THRESHOLD. ANY INTEREST AND PENALTIES RELATED TO UTPS ARE RECORDED AS A COMPONENT OF INCOME TAX EXPENSE. THE ORGANIZATION HAS REVIEWED ITS INCOME TAX POSITIONS AND HAS NOT IDENTIFIED ANY MATERIAL UTPS, INCLUDING ANY TAX POSITIONS THAT WOULD JEOPARDIZE ITS TAX-EXEMPT STATUS, AND THUS HAS NOT RECORDED A LIABILITY AT DECEMBER 31, 2025 OR 2024. THE ORGANIZATION'S INCOME TAX RETURNS ARE SUBJECT TO EXAMINATION BY TAXING AUTHORITIES. THE ORGANIZATION IS NO LONGER SUBJECT TO EXAMINATIONS BY TAX AUTHORITIES FOR YEARS PRIOR TO 2022. CURRENTLY, THERE ARE NO INCOME TAX AUDITS IN PROCESS. 1 BIGELOW LABORATORY FOR OCEAN SCIENCES 60 BIGELOW DRIVE EAST BOOTHBAY ME 04544 016006001 501(C)(3) 48678 0 SUBAWARD - RESEARCH PROJECT MA DIVISION OF MARINE FISHERIES 30 EMERSON AVENUE GLOUCESTER MA 01930 046002284 STATE OF MA 39318 0 SUBAWARD - RESEARCH PROJECT UNIVERSITY OF WASHINGTON 1410 NE CAMPUS PKWY SEATTLE WA 98195 916001537 501(C)(3) 8126 0 SUBAWARD - RESEARCH PROJECT 3 0 STIPENDS TO STUDENTS 45 152750 GIFT CARDS AND FOOD TO STUDENTS 22 13816 RENT ASSISTANCE TO STUDENTS 4 13090 CHILD CARE ASSISTANCE TO STUDENTS 1 120 PART I, LINE 2: GRANTS TO ORGANIZATIONS - RESEARCH SUBAWARDS: SUB-AWARDEES ARE INCLUDED IN THE INITIAL PROPOSAL PROCESS FOR THE PRIME AWARD. PAYMENTS TO SUBAWARDEES ARE SENT AFTER THE INSTITUTE RECEIVES AN ITEMIZED INVOICE THAT ALIGNS WITH THE BUDGET. THE INVOICE IS REVIEWED BY THE ORGANIZATION'S DIRECTOR OF SCIENCE PRIOR TO PAYMENT. GRANTS AND ASSISTANCE TO INDIVIDUALS - STUDENT STIPENDS: STUDENTS ARE SELECTED FOR STIPENDS TO HELP WITH LIVING EXPENSES, BASED ON EVIDENCE OF FINANCIAL NEED. STIPENDS ARE AWARDED IN 4 INSTALLMENTS. STUDENTS MUST REMAIN IN THE PROGRAM AND MEET ALL PROGRAM REQUIREMENTS IN ORDER TO RECEIVE PAYMENT. X X X X X 0 0 0 0 0 0 0 1 0 ANDREA BODNAR SCIENCE DIRECTOR 219491 0 0 0 270 0 0 0 23131 0 242892 0 0 0 BONNIE FENDROCK EXECUTIVE DIRECTOR, AS OF 03/2025 183269 0 0 0 1817 0 0 0 2101 0 187187 0 0 0 JOHN DOYLE EDUCATION DIRECTOR 134100 0 0 0 275 0 0 0 39578 0 173953 0 0 0 COLETTE O'NEIL DIRECTOR OF COMMUNICATIONS 132464 0 0 0 254 0 0 0 34403 0 167121 0 0 0 LAURA RICHANE DIRECTOR OF PARTNERSHIP & ENROLLMENT 126608 0 0 0 247 0 0 0 37122 0 163977 0 0 0 KERSTEN LANES DIRECTOR OF FINANCE AND ADMIN. 151803 0 0 0 807 0 0 0 1146 0 153756 0 0 0 PART I, LINE 7 THE ORGANIZATION PAID PERFORMANCE-BASED BONUSES TO THE INDIVIDUALS LISTED IN PART II AS REPORTED IN COLUMN B(II). BONUSES ARE REVIEWED AND APPROVED BY THE GOVERNANCE/PERSONNEL COMMITTEE. X 2 8751 AVG. SELLING PRICE X LAB EQUIPMENT 1 28500 COST 0 0 1 0 PART I, COLUMN (B): THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTORS IN COLUMN (B). FORM 990, PART VI, SECTION A, LINE 2 DAVID WALT AND MICHELE MAY HAVE A FAMILY RELATIONSHIP. JOHN O'CONNOR AND LAURA SEN HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION HAS ITS FORM 990 PREPARED BY AN OUTSIDE ACCOUNTING FIRM. THE ORGANIZATION'S AUDITING AND TAX FIRM PRESENTS THE FORM 990 TO THE AUDIT & FINANCE COMMITTEE PROVIDING AN OPPORTUNITY FOR QUESTIONS AND DISCUSSION. A COMPLETE COPY IS PROVIDED TO ALL MEMBERS OF THE ORGANIZATION'S GOVERNING BODY FOR REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WHICH REQUIRES EACH DIRECTOR, OFFICER AND A MEMBER OF COMMITTEE WITH BOARD-DELEGATED POWERS TO ANNUALLY SIGN A CONFLICT OF INTEREST STATEMENT, DISCLOSING ANY POTENTIAL CONFLICTS OF INTEREST. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE ALL THE MATERIAL FACTS TO THE BOARD OF DIRECTORS OR COMMITTEE CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER SUCH DISCLOSURE AND ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE LEAVES THE BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS DECIDE IF A CONFLICT OF INTEREST EXISTS, AND HOW TO PROCEED REGARDING THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING THE COMPENSATION OF THE EXECUTIVE DIRECTOR AND THE SCIENCE DIRECTOR INCLUDED A REVIEW AND APPROVAL BY A COMMITTEE OF BOARD MEMBERS, WHO REVIEWED COMPARABILITY DATA, INCLUDING SALARY SURVEYS. THE DELIBERATION AND DECISION WERE CONTEMPORANEOUSLY DOCUMENTED IN THE MEETING MINUTES. THE PROCESS LAST OCCURRED IN 2025. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. THE FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON THE MASSACHUSETTS ATTORNEY GENERAL NONPROFIT ORGANIZATIONS / PUBLIC CHARITIES DIVISION WEBSITE. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS A COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS. THE FULL BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR THE SELECTION OF THE INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.